| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444327 | European Journal of Cancer | 2013 | 7 Pages |
Abstract
Compared with the control arm, adjuvant treatment with clodronate may improve the overall survival, bone metastasis-free survival and non-bone metastasis-free (mainly visceral metastases) survival in patients with early breast cancer. However, further meta-analyses involving all known randomised trials with analysis of sub-groups by age or menopausal status, accessing original trial data, should be performed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jianhong Zhu, Yayuan Zheng, Zhikun Zhou,